Bee Venom Skin Firming Cream
NDC Package 84896-006-01
Package Information
Bee Venom Skin Firming Cream (bee venom) cream is relieve redness, swelling and discomfort, improveskin problem condition; support damaged skin repair,accelerate skin health recovery; relieve eczema,rashes and warts and moles, improve overall skincondition. This formulation utilizes a cream delivery system. Marketed by Guangzhou Mizi Biotechnology Co., Ltd., this product is identified by NDC 84896-006 and is authorized under FDA application 505G(a)(3).
Identification & Billing
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Food Additives - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 84896 - Guangzhou Mizi Biotechnology Co., Ltd.
- 84896-006 - Bee Venom Skin Firming Cream
- 84896-006-01 - 50 g in 1 BOTTLE
- 84896-006 - Bee Venom Skin Firming Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84896-006-01 identifies a specific commercial package of 50 g in 1 bottle of Bee Venom Skin Firming Cream, a human over the counter drug labeled by Guangzhou Mizi Biotechnology Co., Ltd.. This cream is formulated for topical use and contains apis mellifera venom; arginine; borneol; cupressus sempervirens leaf oil; panthenol; peppermint oil; protein mdm4; tea tree oil as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Mizi Biotechnology Co., Ltd. on March 12, 2026. The current certification is valid through December 31, 2027.
How is this Guangzhou Mizi Biotechnology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84896000601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.